compounding glp-1 enforcement news The availability of compounded drugs has become easier to obtain, which has doctors and the U.S. Food and Drug Administration sounding the alarm. https://www.wspa.com/news/national/compounded-glp-1-drugs-creating-concern-among-doctors-and-fda Feds warn telehealth companies about

Compounded medications such as those promoted in the Hims & Hers ad arent approved by the Food and Drug Administration

What If You See Nothing Seeing no change from topical AHK-Cu is an entirely plausible outcome, and it's worth saying without spin: the absence of a clinical trial means there's no established response rate to fall short of

Ill be ordering again soon

He specifically didnt want acid reflux to affect his vocal cords and hold him back from singing

Behind Novo and Lilly: The Emerging GLP1 Challengers While Novo and Lilly lead the global GLP1 race, new challengers across the U.S., India, and China are rapidly gaining ground

obviously each of these has very different business models (for example, DRI and CMG are almost completely company owned, while WING is almost exclusively franchised) and are at different places in their growth life cycle, so each deserves slightly (or massively!) different multiples and valuations, but, across the board, these multiples seem pretty rich even in a vacuum